AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

Short Course High-dose Liposomal Amphotericin B for HIV-associated Cryptococcal Meningitis: A phase-II Randomized Controlled Trial

(2018) Joseph N Jarvis et al.   CLINICAL INFECTIOUS DISEASES

Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa

(2018) Síle F. Molloy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis

(2017) Radha Rajasingham et al.   LANCET INFECTIOUS DISEASES

Forgotten but not gone: HIV-associated cryptococcal meningitis

(2016) Joseph N Jarvis et al.   LANCET INFECTIOUS DISEASES

Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis

(2015) Tihana Bicanic et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bacterial Meningitis in Malawian Adults, Adolescents, and Children During the Era of Antiretroviral Scale-up and Haemophilus influenzae Type b Vaccination, 2000–2012

(2014) Emma C. Wall et al.   CLINICAL INFECTIOUS DISEASES

Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes

(2013) Joseph N. Jarvis et al.   CLINICAL INFECTIOUS DISEASES

Pharmacodynamics of Liposomal Amphotericin B and Flucytosine for Cryptococcal Meningoencephalitis: Safe and Effective Regimens for Immunocompromised Patients

(2013) Lucy O'Connor et al.   JOURNAL OF INFECTIOUS DISEASES

Combination Antifungal Therapy for Cryptococcal Meningitis

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis

(2012) Arthur T. Jackson et al.   AIDS

Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis

(2012) Joseph N. Jarvis et al.   AIDS

Population Pharmacokinetics of Conventional and Intermittent Dosing of Liposomal Amphotericin B in Adults: a First Critical Step for Rational Design of Innovative Regimens

(2012) William W. Hope et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Early Mortality in Adults Initiating Antiretroviral Therapy (ART) in Low- and Middle-Income Countries (LMIC): A Systematic Review and Meta-Analysis

(2011) Amita Gupta et al.   PLoS One

Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases

(2010) Joseph N Jarvis et al.   BMC INFECTIOUS DISEASES

Comparison of 2 Doses of Liposomal Amphotericin B and Conventional Amphotericin B Deoxycholate for Treatment of AIDS‐Associated Acute Cryptococcal Meningitis: A Randomized, Double‐Blind Clinical Trial of Efficacy and Safety

(2010) Richard J. Hamill et al.   CLINICAL INFECTIOUS DISEASES

Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions

(2010) Lewis J Haddow et al.   LANCET INFECTIOUS DISEASES

Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India

(2010) Shyam Sundar et al.   NEW ENGLAND JOURNAL OF MEDICINE

High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out

(2009) Joseph N Jarvis et al.   AIDS

Pharmacokinetics and Buccal Mucosal Concentrations of a 15 Milligram per Kilogram of Body Weight Total Dose of Liposomal Amphotericin B Administered as a Single Dose (15 mg/kg), Weekly Dose (7.5 mg/kg), or Daily Dose (1 mg/kg) in Peripheral Stem Cell Transplant Patients

(2009) P. O. Gubbins et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda

(2009) Barbara Amuron et al.   BMC PUBLIC HEALTH

Independent Association between Rate of Clearance of Infection and Clinical Outcome of HIV‐Associated Cryptococcal Meningitis: Analysis of a Combined Cohort of 262 Patients

(2009) Tihana Bicanic et al.   CLINICAL INFECTIOUS DISEASES

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

(2008) Stephen D Lawn et al.   AIDS

Dose Response Effect of High‐Dose Fluconazole for HIV‐Associated Cryptococcal Meningitis in Southwestern Uganda

(2008) Nicky Longley et al.   CLINICAL INFECTIOUS DISEASES

High‐Dose Amphotericin B with Flucytosine for the Treatment of Cryptococcal Meningitis in HIV‐Infected Patients: A Randomized Trial

(2008) Tihana Bicanic et al.   CLINICAL INFECTIOUS DISEASES